- €243.36m
- €948.47m
- €736.09m
- 61
- 84
- 73
- 88
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.77 | ||
| PEG Ratio (f) | 0.5 | ||
| EPS Growth (f) | 21.48% | ||
| Dividend Yield (f) | 3.09% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.79 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.25 | ||
| Price to Sales | 0.32 | ||
| EV to EBITDA | 6.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.69% | ||
| Return on Equity | 7.98% | ||
| Operating Margin | 8.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 527.86 | 573.89 | 689.49 | 728.22 | 736.09 | 803.4 | 890.13 | 6.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -4.01 | -44.03 | +105.23 | +1.42 | -8.85 | -2.86 | +21.48 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LNA Sante SA, formerly known as Le Noble Age SA, is a France-based company specializes in the operation and management of comprehensive care establishments for dependent elderly people. The Company's residences provide care and assistance for elderly people with a variety of needs, from those with a high level of independence, to those who are completely dependent. LNA Sante SA is also engaged in real estate operations. The Company has residences in France and Belgium. LNA Sante SA operates through its several subsidiaries, including Le Parc de Diane Sarl, Institut Medicalise de Mar Vivo, Gerhome, Residence le Point du Jour and the home healthcare service provider ARAIR Assistance, as well as ARAIR Group's support and training services, among others.
Directors
- Jean-Paul Siret CHM (67)
- Damien Billard DCE
- Willy Siret DCE
- Jean-Francois Billet DRC (53)
- Sophie Breton DRC (40)
- Robert Dardanne DRC (66)
- Philippe De Verdalle DRC (60)
- Daniel Braud IND (68)
- Christine Lioret IND (49)
- Flavie Lorre IND (45)
- Patricia Rosiod IND (61)
- Maud Roux IND (41)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 30th, 1992
- Public Since
- June 6th, 2006
- No. of Employees
- 7,879
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Euronext - Paris- Shares in Issue
- 10,225,249
- Address
- 7 Boulevard Auguste Priou, VERTOU, 44120
- Web
- https://www.lna-sante.com/
- Phone
- +33 240160161
- Auditors
- In Extenso Audit
Upcoming Events for LNA
Similar to LNA
Bastide le Confort Medical SA
Euronext - Paris
Clariane SE
Euronext - Paris
Emeis SA
Euronext - Paris
Klea Holding
Euronext - Paris
Ramsay Generale De Sante SA
Euronext - Paris
FAQ
What is the LNA Sante SA share price?
As of Today at 21:47 UTC, shares in LNA Sante SA are trading at €23.80. This share price information is delayed by 15 minutes.
How has the LNA Sante SA share price performed this year?
Shares in LNA Sante SA last closed at €23.80 and the price had moved by +22.3% over the past 365 days. In terms of relative price strength the LNA Sante SA share price has outperformed the FTSE Global All Cap Index by +20.15% over the past year.
What are the analyst and broker recommendations for LNA Sante SA?
The overall consensus recommendation for LNA Sante SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the LNA Sante SA dividend yield?
The LNA Sante SA dividend yield is 2.52% based on the trailing twelve month period.
Does LNA Sante SA pay a dividend?
Last year, LNA Sante SA paid a total dividend of €0.60, and it currently has a trailing dividend yield of 2.52%. We do not have any data on when LNA Sante SA is to next pay dividends.
When does LNA Sante SA next pay dividends?
We do not have data on when LNA Sante SA is to next pay dividends. The historic dividend yield on LNA Sante SA shares is currently 2.52%.
How do I buy LNA Sante SA shares?
To buy shares in LNA Sante SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of LNA Sante SA?
As of the previous close price of €23.80, shares in LNA Sante SA had a market capitalisation of €243.36m.
Where are LNA Sante SA shares listed?
Here are the trading details for LNA Sante SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: LNA
What kind of share is LNA Sante SA?
Based on an overall assessment of its quality, value and momentum LNA Sante SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a LNA Sante SA share price forecast for 2025?
The analyst consensus target price for shares in LNA Sante SA is €32.30. That is 35.71% above the last closing price of €23.80.
Analysts covering LNA Sante SA currently have a consensus Earnings Per Share (EPS) forecast of €2.24 for the next financial year.
Find out moreWhat is the trend in the LNA Sante SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LNA Sante SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +2.58%.
As of the last closing price of €23.80, shares in LNA Sante SA were trading -1.82% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the LNA Sante SA PE Ratio?
The LNA Sante SA PE ratio based on its reported earnings over the past 12 months is 8.77. The shares last closed at €23.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of LNA Sante SA?
LNA Sante SA's management team is headed by:
- Jean-Paul Siret - CHM
- Damien Billard - DCE
- Willy Siret - DCE
- Jean-Francois Billet - DRC
- Sophie Breton - DRC
- Robert Dardanne - DRC
- Philippe De Verdalle - DRC
- Daniel Braud - IND
- Christine Lioret - IND
- Flavie Lorre - IND
- Patricia Rosiod - IND
- Maud Roux - IND